Isegawa K, Hirooka Y, Katsuki M, Kishi T, Sunagawa K. Angiotensin II type 1 receptor expression in astrocytes is upregulated leading to increased mortality in mice with myocardial infarction-induced heart failure. Am J Physiol Heart Circ Physiol 307: H1448 -H1455, 2014. First published September 12, 2014 doi:10.1152/ajpheart.00462.2014.-Enhanced central sympathetic outflow worsens left ventricular (LV) remodeling and prognosis in heart failure after myocardial infarction (MI). Previous studies suggested that activation of brain angiotensin II type 1 receptors (AT 1R) in the brain stem leads to sympathoexcitation due to neuronal AT 1R upregulation. Recent studies, however, revealed the importance of astrocytes for modulating neuronal activity, but whether changes in astrocytes influence central sympathetic outflow in heart failure is unknown. In the normal state, AT1R are only weakly expressed in astrocytes. We hypothesized that AT1R in astrocytes are upregulated in heart failure and modulate the activity of adjacent neurons, leading to enhanced sympathetic outflow. In the present study, by targeting deletion of astrocyte-specific AT 1R, we investigated whether AT1R in astrocytes have a key role in enhancing central sympathetic outflow, and thereby influencing LV remodeling process and the prognosis of MI-induced heart failure. Using the Cre-LoxP system, we generated glial fibrillary acidic protein (GFAP)-specific AT1R knockout (GFAP/ AT 1RKO) mice. Urinary norepinephrine excretion for 24 h, as an indicator of sympathoexcitation, was significantly lower in GFAP/ AT 1RKO-MI mice than in control-MI mice. LV size and heart weight after MI were significantly smaller in GFAP/AT 1RKO mice than in control mice. Prognosis was significantly improved in GFAP/ AT 1RKO-MI mice compared with control-MI mice. Our findings indicated that AT 1R expression was upregulated in brain stem astrocytes in MI-induced heart failure, which worsened LV remodeling and prognosis via sympathoexcitation. Thus, in addition to neuronal AT 1R, AT1R in astrocytes appear to have a key role in enhancing central sympathetic outflow in heart failure.
astrocyte; angiotensin II type 1 receptor; sympathetic nervous system; heart failure ENHANCED central sympathetic outflow is a cardinal manifestation of heart failure, which influences the left ventricular (LV) remodeling process and eventually worsens prognosis (10, 45) . Activation of brain angiotensin II type 1 receptors (AT 1 R) enhances sympathetic outflow in experimental heart failure (12, 13, 30) . Furthermore, activation of AT 1 R has a major role in the production of reactive oxygen species (ROS) in the brain stem and hypothalamus (5, 17) . For example, ROS blockade in the central nervous system by intracerebroventricular injection of superoxide dismutase or tempol prevents sympathoexcitation after myocardial infarction (MI) (19) . In particular, AT 1 Rinduced ROS production in the rostral ventrolateral medulla (RVLM) contributes to enhance the sympathetic outflow in heart failure (12, 13) . Previous studies examined the role of ROS related to neuronal AT 1 R stimulation in the brain stem nuclei, including the RVLM, and investigated downstream signal transmission and channel abnormalities (6, 51) . Findings from these studies suggested that neuronal AT 1 R are responsible for the enhanced sympathetic outflow in heart failure. Whether neuronal or glial (e.g., astrocytic) AT 1 R activation is more important for central sympathetic outflow in heart failure, however, is unknown.
Astrocytes, the most abundant brain cell type, provide structural and metabolic support for neuronal networks (3, 46) and modulate neuronal activity via transmitters such as ATP, glutamate, and ␥-aminobutyric acid (GABA) (14, 15, 37, 40) . Although AT 1 R are weakly expressed in astrocytes under basal conditions (28, 35) , they have important roles in abnormal conditions, such as experimental autoimmune encephalomyelitis, and in the regulation of leukocyte infiltration into the central nervous system in response to a neurodegenerative stimulus as well as hypoxia (7, 11, 26) . AT 1 R in glia cells in the RVLM are thought to be involved in the regulation of blood pressure associated with sympathetic activation (2) . In addition, a recent study suggested that astrocytes in the RVLM regulate sympathetic activity via the release of ATP and the progression of LV remodeling after MI (31) . Blockade of brain AT 1 R inhibits increased sympathetic hyperactivity in animals with hypertension and heart failure, but not in animals in a normal state (18, 27, 30) . Therefore, we consider that brain stem AT 1 R in cells other than neurons, particularly astrocytes, might be upregulated in MI-induced heart failure, thereby affecting enhanced central sympathetic outflow. To determine the functional importance of AT 1 R on astrocytes in heart failure associated with sympathetic activation, we investigated the role of AT 1 R on astrocytes using mice with targeted deletion of glial fibrillary acidic protein (GFAP)-specific AT 1 R by applying the Cre-loxP system in MI-induced heart failure. We also examined the LV remodeling process and survival rates associated with sympathetic activity after MI.
MATERIALS AND METHODS
Animals. All procedures and animal care were approved by the Committee on the Ethics of Animal Experiments, Kyushu University Graduate School of Medical and Pharmaceutical Sciences, and performed in accordance with the Guidelines for Animal Experiments at Kyushu University. We obtained FVB-Tg (GFAP-Cre) mice and C57B6-Agtr1a (angiotensin II receptor, type 1a) mice from Jackson Laboratory (Bar Harbor, ME) (29, 34, 39, 49) . GFAP-specific AT 1R-deficient (GFAP/AT 1RKO) mice were generated by crossing AT1R f/f and GFAP-Cre mice. Experiments were performed in adult transgenic mice (8 -12 wk of age, 25-30 g). The total number of animals used in the present study was 15 (control-sham mice), 22 (control-MI mice), 15 (GFAP/AT 1RKO-sham mice), and 20 (GFAP/ AT 1RKO-MI mice). Eight of 22 control-MI mice and 2 of 20 GFAP/AT 1RKO-MI mice were not included in further analysis except for survival rates, due to short survival.
Preparation of heart failure model. We induced MI by permanent ligation and subsequent chronic heart failure using surgical procedures described in detail elsewhere (32) . Under anesthesia with ketamine hydrochloride (80 mg/kg ip) and xylazine (10 mg/kg ip) and mechanical ventilation, the thorax was opened at the left intercostal space, and the left coronary artery was ligated 2-3 mm from its origin with 8-0 silk. The chest wall and skin were closed with sutures. Sham control mice underwent the same surgical procedure without left coronary artery ligation. We evaluated LV remodeling every week up to 4 wk after surgery, a time point selected based on previous reports (21, 23) .
Immunohistochemistry. At 4 wk after the surgery, the mice were euthanized and perfused transcardially with 20 ml PBS followed by 50 ml 4% paraformaldehyde in PBS. The brains were removed and postfixed overnight in 4% paraformaldehyde, placed in 20% sucrose solution for 12 h, and then placed in 30% sucrose solution for 12 h. The brain stems were cut coronally (12-m slices) using a cryostat (Leica CM 3050). The brain slices were permeabilized with 0.1% Triton X-100 in PBS and incubated to inhibit nonspecific staining due to endogenous biotin using a Biotin Blocking System Kit (Dako, Japan). The slices were then incubated with goat anti-GFAP antibody Western blot analysis. Western blot analysis was used to examine AT1R protein expression in different tissues. At 4 wk after surgery, the mice were euthanized with an overdose of pentobarbital sodium, and brain stems were removed and homogenized. The protein concentration was determined using a bicinchoninic acid protein assay kit (Pierce Chemical, Rockford, IL). A 15-mg protein aliquot from each sample was separated on a polyacrylamide gel containing 10% SDS. The proteins were subsequently transferred onto polyvinylidene difluoride membranes (Immobilon-P membranes; Millipore, Billerica, MA). The membranes were incubated in immunoreaction enhancer solution (Can Get Signal; Toyobo, Osaka, Japan) with a rabbit IgG polyclonal antibody against AT1R (1:500; Santa Cruz Biotechnology). The membranes were then incubated with horseradish peroxidase-conjugated horse anti-rabbit IgG antibody (1:10,000). We used GAPDH as an internal control. Immunoreactivity was detected by enhanced chemiluminescence autoradiography (ECL Western blotting detection kit; Amersham Pharmacia Biotech, Uppsala, Sweden), and the film was analyzed using the public domain software, NIH Image.
RT-quantitative PCR analysis. RT-quantitative PCR analysis was performed to examine the expression of AT1R mRNA in different tissues. At 4 wk after surgery, the mice were euthanized and their brain stems removed. Total brain stem RNA was isolated using Isogen (Nippon Gene, Toyama, Japan). cDNA was generated using the ReverTra Ace qPCR RT Kit (Toyobo). The following gene-specific primers were used: AT1R, forward primer 5=-TGGGCGTCATCCAT-GACTGTA-3= and reverse primer 5=-TGAGTGCGACTTGGC-CTTTG-3=; and ␤-actin, forward primer 5=-CATCCGTAAGACCTC-TATGCCAAC-3= and reverse primer 5=-ATGGAGCCACCGATC-CACA-3=. These primers were purchased from Takara Bio (Shiga, Japan). Real-time PCR was performed using the ABI prism 7500 Sequence Detection System (Applied Biosystems, Foster City, CA). All data were subsequently normalized to the ␤-actin mRNA level and expressed as mRNA relative fold-change.
Twenty-four hour urinary norepinephrine excretion. Sympathetic nervous system activity was evaluated by measuring 24-h urinary norepinephrine (NE) excretion using HPLC at 4 wk after surgery (22, 47, 48) .
Cardiac echocardiography. Transthoracic cardiac echocardiography was performed using the VEVO 2100 Ultrasound System with 40 MHz MS550D transducer under anesthesia (1.5% isoflurane) (42) . We evaluated LV remodeling by echocardiography before surgery and every week up to 4 wk after surgery. LV end-diastolic dimension (EDD) and end-systolic dimension (ESD) were determined by Mmode echocardiography. Ejection fraction (EF) was calculated based on the following formulas (44): end-diastolic volume (EDV) ϭ 7 ϫ LVEDD 3 /(2.4 ϩ LVEDD); end-systolic volume (ESV) ϭ 7 ϫ LVESD 3 /(2.4 ϩ LVESD); and EF ϭ (EDV Ϫ ESV)/EDV ϫ 100 (%). Measurement of heart weight. At 4 wk after surgery, mice were euthanized by an overdose of pentobarbital sodium, the hearts were removed, and the heart weights were measured.
Statistical analysis. Data are expressed as means Ϯ SE. Statistical analyses were performed using an unpaired t-test when comparing data between two groups. A one-way ANOVA was used to compare protein and mRNA expression levels, LVEDD, LVESD, EF, heart weight (HW)/body weight (BW), and urinary NE excretion between groups. Survival rates were analyzed using the standard Kaplan-Meier analysis. Differences were considered to be statistically significant at a P value of Ͻ0.05.
RESULTS
Generation of astrocyte-specific AT 1 R knockout mice. We achieved GFAP-specific deletion of AT 1 R by creating transgenic mice expressing AT 1 R f/f and Cre recombinase driven by a GFAP promoter. Transgene-specific primers were used to genotype each mouse derived from these crosses (Fig. 1 ). Five generations of breeding were required to generate these transgenic mice, and several additional generations were required to obtain a sufficient number of mice. Blood pressure, heart rate, BW, HW, urinary NE, and the echocardiography data (LVEDD, LVESD, EF) did not differ significantly between GFAP/AT 1 RKO mice and control mice (Table 1) . We observed no obvious behavioral differences, such as in locomotor, grooming, or freezing activity, between control mice and GFAP/AT 1 R mice. Western blot analysis and RT-quantitative PCR (qPCR) were used to examine AT 1 R expression in various organs obtained from control mice and GFAP/ AT 1 RKO mice (n ϭ 3 for each). AT 1 R protein and mRNA expression in the brain stem, heart, kidney, and liver did not differ significantly between control mice and GFAP/AT 1 RKO mice (Fig. 1) . Because brain tissues comprise neurons, astrocytes, and other glial cells, it was difficult to examine AT 1 R expression only in astrocytes. AT 1 R expression in the brain stem was not decreased in GFAP/AT 1 RKO mice, consistent with previous reports that AT 1 R in astrocytes are only weakly expressed under basal conditions. To confirm AT 1 R knockout in GFAP-positive cells, we examined AT 1 R expression in astrocytes by immunohistochemistry.
Immunohistochemical analysis for GFAP and/or AT 1 R in the RVLM in GFAP/AT 1 RKO mice and control mice. Doublestaining of GFAP and AT 1 R in control-sham mice revealed no AT 1 R in GFAP-positive cells (Fig. 2) , whereas AT 1 R were expressed in GFAP-positive cells in control-MI mice. AT 1 R were not observed in GFAP-positive cells in GFAP/AT 1 RKO-MI mice. This finding indicated the depletion of AT 1 R in GFAPpositive cells. Although we were able to see some neuronal AT 1 R, they were difficult to detect without high-laser intensity.
AT 1 R expression in the brain stem in GFAP/AT 1 RKO mice and control mice. AT 1 R protein and mRNA expression levels in the brain stem were significantly higher in control-MI mice than in control-sham mice (Fig. 3) . Control-MI mice exhibited a twofold increase in mRNA (n ϭ 9, P Ͻ 0.01) and a twofold increase in AT 1 R protein (n ϭ 5, P Ͻ 0.01). AT 1 R protein and mRNA expression did not differ significantly between controlsham mice and GFAP/AT 1 RKO-sham mice. AT 1 R protein and mRNA expression levels were not increased in GFAP/ AT 1 RKO-MI mice compared with GFAP/AT 1 RKO-sham mice. Together with the immunohistochemistry results, these findings indicate AT 1 R depletion in GFAP-positive cells.
Twenty-four hour urinary NE excretion in GFAP/AT 1 RKO mice and control mice. Urinary NE excretion measured at 4 wk after surgery was significantly increased in control-MI mice compared with control-sham mice (Fig. 4) . In GFAP/ AT 1 RKO-MI mice, however, the increase in the urinary NE excretion was significantly inhibited (n ϭ 8 -9 for each, P Ͻ 0.05).
Echocardiographic data and heart weight in GFAP/ AT 1 RKO mice and control mice. MI caused LV dilation and dysfunction in control-MI mice and GFAP/AT 1 RKO-MI mice, based on the increased LVEDD/LVESD and decreased EF (Fig. 5, A-C f/f mice are GFAP-specific AT1R knockout (GFAP/AT1RKO) mice. GFAP-Cre (Ϫ) and AT1R f/f mice are control mice. B: quantification of Western blot analysis of AT1R protein in the brain stem, heart, kidney, and liver (n ϭ 3 for each). C: RT-PCR of AT1R mRNA in the brain stem, heart, kidney, and liver (n ϭ 3 for each). Data are shown as means Ϯ SE. GFAP, glial fibrillary acidic protein; AT1R, angiotensin II type 1 receptors. Values are means Ϯ SE. AT1R, angiotensin II type 1 receptors; BW, body weight; EF, ejection fraction; GFAP, glial fibrillary acidic protein; HR, heart rate; HW, heart weight; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end systolic diameter; NE, norepinephrine excretion; SBP, systolic blood pressure. n ϭ 6 for each, P Ͻ 0.05). The HW/BW ratio was significantly increased in control-MI mice compared with control-sham mice (Fig. 5D) . The HW/BW ratio did not differ significantly between control-sham mice and GFAP/AT 1 RKO-sham mice. The HW/BW ratio in GFAP/AT 1 RKO-MI mice, however, was significantly smaller than that in control-MI mice (n ϭ 8 -11, P Ͻ 0.001; Fig. 5D ).
Survival in GFAP/AT 1 RKO mice and control mice. Survival analysis was performed during the 30-day study period. There were no deaths among control-sham mice (n ϭ 15) or GFAP/ AT 1 RKO-sham mice (n ϭ 15). Survival rates were significantly better in GFAP/AT 1 RKO-MI mice than in control-MI mice (GFAP/AT 1 RKO-MI 90% vs. control-MI 63%, P Ͻ 0.01, n ϭ 20 and 22; Fig. 6 ).
DISCUSSION
The findings of the present study indicated that AT 1 R in astrocytes were upregulated in MI-induced heart failure in mice, thereby enhancing central sympathetic outflow, progres- sion of remodeling process, and poor prognosis. Although AT 1 R were only weakly expressed in astrocytes under basal conditions, MI led to the upregulation of AT 1 R expression levels, mainly in astrocytes. In mice with GFAP-specific AT 1 R deletion using a Cre-LoxP system, upregulation of brain AT 1 R was inhibited despite the preservation of neuronal AT 1 R expression. Furthermore, LV remodeling after MI was attenuated and survival rates were improved in association with the inhibition of enhanced central sympathetic outflow in these mice. Our findings provide novel information indicating that AT 1 R in astrocytes play a key role in enhanced central sympathetic outflow and are related to the development of LV remodeling and prognosis in MI-induced heart failure. These findings are the first to indicate that AT 1 R in astrocytes, as well as in neurons, have a key role in the process of sympathoexcitation in MI-induced heart failure. While previous reports suggest that neuronal AT 1 R cause sympathoexcitation, there has been no evidence showing that only neuronal AT 1 R contribute to sympathoexcitation. In rabbits with chronic heart failure induced by rapid pacing, Gao et al. (12, 30) demonstrated increased AT 1 R expression levels in the RVLM, but they did not distinguish neurons from other cell types in the brain stem tissue sample. Astrocytes were previously thought to be nonexcitable support cells of the brain, but recent findings refute this notion (46) . Furthermore, despite the fact that AT 1 expression is very weak in normal states, it is increased in hypoxic conditions (7) . Moreover, insertion of an AT 1 R transgene into the RVLM using adenoviral vectors results in the expression of AT 1 R in the glia as well as increased blood pressure, probably due to increased sympathetic activity (2) . Taken together, we considered that AT 1 R expression in astrocytes increases, thereby modulating neuronal activity in the RVLM in heart failure. It is difficult to examine only the AT 1 R expressed in astrocytes, because brain tissues comprise neurons and glial cells, including astrocytes. In systemic AT 1 R knockout mice, the direct effects of non-AT 1 R and their subsequent indirect effects on LV remodeling cannot be distinguished, because chronic hypotension is observed and the hemodynamics differ compared with that in normal mice (43) . We used the Cre-loxP system to determine whether AT 1 R activation in neurons or astrocytes is more crucial in heart failure. AT 1 R expression in the brain stem was not decreased in GFAP/AT 1 RKO mice compared with control mice (Fig. 1) . Therefore, we consider that AT 1 R in neurons are preserved in GFAP/AT 1 RKO mice. In addition, our immunohistochemistry findings confirmed that although AT 1 R in GFAP-positive cells were observed in control-MI mice, they were not expressed in GFAP/AT 1 RKO-MI mice. Therefore, we were able to show the functional importance of AT 1 R in astrocytes in MI-induced heart failure by using these GFAP/AT 1 RKO mice. The present study demonstrated that AT 1 R are upregulated mainly in astrocytes in MI-induced heart failure. Immunohistochemistry showed that astrocytes weakly express AT 1 R in control-sham and GFAP/AT 1 RKO-sham mice. Consistent with our findings, a previous report indicated difficulties in identifying AT 1 R in cultured astrocytes using a variety of approaches, including immunohistochemistry, RT-qPCR, inositol phosphatase-signaling assay, and angiotensin receptor-binding assay (35) . Other studies localizing AT 1 R expression in astrocytes have relied on immunohistochemical methods (4, 11, 26) . We also examined AT 1 R expression in the brain stem by Western blotting and RT-qPCR. The expression of AT 1 R protein and mRNA in the brain stem was not significantly increased in GFAP/AT 1 RKO-MI mice compared with GFAP/ AT 1 RKO-sham mice, although the expression was significantly higher in control-MI mice than in control-sham mice. These findings suggest that MI upregulates AT 1 R mainly in astrocytes, and GFAP-specific AT 1 R knockout inhibits upregulation of brain AT 1 R in MI-induced heart failure.
Targeted deletion of AT 1 R in astrocytes improved the survival rates of MI-induced heart failure. Our echocardiography results revealed that LV dilation after MI was attenuated in GFAP/AT 1 RKO mice compared with control mice. In addition, the HW/BW ratio was significantly smaller in GFAP/ AT 1 RKO-MI mice than in control-MI mice. These findings indicate that LV remodeling induced by MI was attenuated in GFAP/AT 1 RKO mice. Previous reports suggest that sympathetic hyperactivity after MI results from increases in cardiac sympathetic afferent activity and plasma angiotensin II, and the improvement of LV remodeling by blockade of brain AT 1 R leads to a persistent attenuation of these stimuli and therefore prevents sympathetic hyperactivity (19, 20) . In brief, sympathoinhibition induced by the blockade of brain AT 1 R attenuates LV remodeling after MI. In the present study, GFAP/AT 1 RKO mice did not have excessive sympathetic activity, as described above. Therefore, our findings suggest that the targeted deletion of AT 1 R in astrocytes improved survival rates, which was mediated by the attenuation of LV remodeling, probably due to sympathoinhibition.
Previous reports suggested that upregulation of neuronal AT 1 R led to an increase in brain oxidative stress, and the sympathetic nervous system is activated by brain oxidative stress (12, 13) . We previously reported that gene transfer of manganese superoxide dismutase in the RVLM by adenoviral vectors decreases the oxidative stress level and inhibits sympathetic activity (24) . Because the transfection of adenoviral vectors favors astrocytes over neurons (9) , it is possible that gene transfer of manganese superoxide dismutase decreases AT 1 R-induced oxidative stress in astrocytes. Therefore, we consider that GFAP-specific AT 1 R knockout could inhibit sympathetic activity by reducing oxidative stress in astrocytes. In addition, microglia in the paraventricular nucleus of the hypothalamus are activated after MI and contribute to LV remodeling (38) . Astrocytes and microglia interact to regulate each other's function and neuronal function, and astrocytes also produce anti-inflammatory cytokines and neurotrophic factors that promote central nervous system repair (8) . Thus it is possible that microglia are also involved in the process of sympathoexcitation after MI via neuroimmune communication. Taken together, we consider that GFAP-specific AT 1 R knockout attenuates activation of the sympathetic nervous system, probably by inhibiting reactive oxygen species (ROS) production in MI-induced heart failure, although further studies are required to explore this issue.
Our immunohistochemistry data suggested that GFAP-positive cells were decreased, but it was technically difficult to quantify actual differences in the number of GFAP-positive cells, and the degree of GFAP antibody staining was different between control-MI and control-sham mice. We cannot determine from these results whether this change indicates a functional change of astrocytes. It is possible, however, that normal astrocytes change to abnormal astrocytes in MI-induced heart failure. A recent research focus has been transmitters released by astrocytes that modulate neuronal activity. Astrocytes are closely involved in the control of the biosynthesis and turnover of glutamate and GABA, and regulate neural function via the release of glutamate, ATP, and other signaling molecules (8, 40) . Moreover, GABA-transporters expressed in astrocytes contribute to GABA tone in various neural circuits, and astrocytes regulate sympathetic outflow (36) . Although the role of astrocytes in heart failure has not been examined until recently, a very recent report suggests that the actions of ATP derived from astrocytes within the RVLM contribute to increase sympathetic outflow and facilitate LV remodeling (31) . Further studies are necessary to address these questions with full sets of data.
This study has several limitations. First, examination of AT 1 R expression should be considered with some caution due to the unreliability of AT 1 R antibodies (16) . Even if the AT 1 R antibody used in the present study led to an overestimation of protein expression to some extent, however, we were still able to detect changes in AT 1 R expression. Moreover, we also examined AT 1 R mRNA by RT-qPCR, and confirmed that the AT 1 R depletion profile in astrocytes changed after MI using the Cre-loxP system. Second, we used the GFAP antibody as an astrocyte marker in this study and did not quantitatively evaluate the signal intensity of GFAP-positive cells, because GFAP labels a limited number of astrocytes (33, 50) . GFAP is a marker of terminally differentiated astrocytes, however, and almost all studies of astrocyte development rely on GFAP expression (1, 33) . Third, we did not evaluate other brain sites, such as the paraventricular nucleus of the hypothalamus, that are important for activation of the sympathetic nervous system in heart failure (25, 41) . We cannot exclude the possibility that other areas in the brain are similarly altered in heart failure. Within the brain stem, we focused on the RVLM for immunohistochemical analysis because of the importance of the RVLM based on previous studies (12, 30) . The RVLM is responsible for the enhanced central sympathetic drive in heart failure, in addition to the role of AT 1 R in the RVLM (12, 30) . Also, we performed Western blot and PCR analyses on the entire brain stem to obtain an adequately sized sample and were not able to perform separate analyses of the nucleus tractus solitarii and RVLM. Investigation of other brain areas involved in autonomic regulation is required in future studies. Fourth, we examined urinary NE as a marker of sympathetic activity and did not directly measure sympathetic activity in awake mice due to technical difficulties. Nonetheless, previous studies suggested that urinary NE is a supportive and indirect parameter of chronic sympathetic activity in animal models (22, 47, 48) . Finally, we did not measure ROS in the present study, because it is technically difficult to distinguish between astrocyte-derived and neuron-derived ROS. It is possible that both astrocytic and neuronal ROS are involved in sympathoexcitation in MI-induced heart failure. Further studies are needed to clarify the precise mechanism by which upregulation of brain AT 1 R causes sympathoexcitation via ROS.
In conclusion, our findings indicate that AT 1 R in astrocytes are upregulated in MI-induced heart failure, thereby worsening LV remodeling and prognosis via sympathoexcitation. It would be interesting to elucidate the role of AT 1 R in astrocytes in the pathophysiology of heart failure, as well as its potential as a therapeutic target.
